Sleuthy Google upstart Calico forges a rare biotech collaboration on aging with Novartis-backed C4
The elusive but widely buzzed about Calico, a startup bankrolled by Google to find new therapies for aging, has hitched up with protein degeneration-focused C4 …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.